CAT and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, tumor-produced ROS likely caused NK cell dysfunction in chronic myelogenous leukemia (CML), since catalase could restore NK cell cytotoxic capacity against primary tumor cells obtained from patients affected with this malignancy [79].